Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Janie Peacock"'
Autor:
Jen Jen Yeh, Janie Peacock, Temitope O. Keku, Robert S. Sandler, Channing J. Der, Tara C. Rubinas, Xiang Jun Shen, Hong Jin Kim, Timothy D. Martin, Elizabeth D. Routh
Publikováno v:
Molecular Cancer Therapeutics. 8:834-843
Phase II clinical trials of mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitors are ongoing and ERK1/2 activation is frequently used as a biomarker. In light of the mutational activation of BRAF and KRAS in c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::209f86326b178ccb779394c788508389
https://doi.org/10.1158/1535-7163.mct-08-0972
https://doi.org/10.1158/1535-7163.mct-08-0972
Statistical strategies to improve the efficiency of molecular studies of colorectal cancer prognosis
Autor:
Joseph G. Ibrahim, Robert S. Sandler, Joel E. Tepper, Janie Peacock, Temitope O. Keku, Pingping Qu, Haitao Chu, Xiang Jun Shen
Publikováno v:
British Journal of Cancer
The evaluation of tumour molecular markers may be beneficial in prognosis and predictive in therapy. We develop a stopping rule approach to assist in the efficient utilisation of resources and samples involved in such evaluations. This approach has a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74712ef0927420f400795f8ef3297c0c
http://europepmc.org/articles/PMC2607226
http://europepmc.org/articles/PMC2607226
Autor:
Temitope O. Keku, Xiang J. Shen, Janie Peacock, Pauline K. Lund, Robert S. Sandler, Samuel Nzewi, Wen Sui
Publikováno v:
Gastroenterology. 136:A-745
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f581481b35390656b285a075e36303d2
https://doi.org/10.1016/s0016-5085(09)63438-7
https://doi.org/10.1016/s0016-5085(09)63438-7